[Evaluation of the anti-platelet aggregation action of oxovinca in the diffuse vascular deterioration syndrome].
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010974:Platelet Aggregation / Q000187:drug effects*; D013577:Syndrome; D014748:Vinca Alkaloids / Q000627:therapeutic use*; D014749:Vincamine / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000925:Anticoagulants; D010919:Placebos; D014748:Vinca Alkaloids; D014749:Vincamine; C026347:oxovinca
Valoración de la acción antiagregante plaquetaria de oxovinca en el síndrome de deterioro difuso de origen vascular.